Searched for
ROCHE AG
Roche moves SC against Natco’s launch of generic Risdiplam in IndiaF. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a g...- Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche pleaThe Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular a...
- Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent disputeThe Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the paten...
- Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patentThe Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing pu...
- Supreme Court asks Zydus Lifesciences to approach Delhi HC over ban on selling breast cancer drug SigrimaThe Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents t...
- Delhi HC allows Zydus Lifesciences to sell breast cancer drug SigrimaThe Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations of it being si...
- New antibody tests offer better snapshot of Covid-19 immunityAntibodies are markers of infection, and testing for them helps health officials see how widely the virus has spread. Until now, most tests...
- Roche gets US nod for Covid-19 antibody testHospitals and reference laboratories can run the Elecsys Anti-SARS-CoV-2 test on one of Roche’s analysis platforms, the company said. Roche...
- CCI orders detailed probe against pharma major RocheAccording to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.
- Where to hide if Trump's policies go bad? Top investors say go for goldThe amount of political risk being created by Trump and his administration is going to create an enormous amount of international tension a...
- Court defers decision on Roche's plea against Zydus' cancer drugRoche sued Zydus Cadila and the DCGI last week, alleging that the Indian company launched its product, Vivitra, in the country without gene...
- Ranbaxy sues USFDA for revoking approvals for 2 drugs; stock down by over 4%At 10:00 a.m.; the stock was at Rs 617.45, down 1.80 per cent, on the BSE. It touched a high of Rs 630 and a low of Rs 614.10 in early trad...
- Swiss voters reject strictest executive pay limitsSwiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees on Sunday.
- Pfizer to appeal India decision to revoke cancer drug patentPfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...
- Roche Holding AG makes $5.7 bn offer for Illumina IncA takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.
- Roche says half-year profit down 29 per centPharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.
- Roche seals $47-b Genentech dealSwiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...
- Roche makes 'cheaper' bid for GenentechRoche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.
- No antidote to stop copies of patented drugs: Health minHealth ministry says not equipped with technical expertise to stop domestic pharmaceutical cos from copying patented drugs.
- Roche to force through Ventana mergerPharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.
Load More
